ArticleCureus2025
Peripartum Anesthetic Care of a Parturient With Arnold-Chiari Malformation and Factor XI Deficiency: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arnold-Chiari malformation (ACM) and Factor XI (FXI) deficiency are rare conditions that pose distinct anesthetic challenges in the obstetric population. While each condition has been managed individually with varying anesthetic approaches, their coexistence in a single patient significantly complicates peripartum decision-making, particularly regarding the safety of neuraxial anesthesia and the risk of hemorrhage. We report the case of a 26-year-old G2P1011 woman at 39 weeks of gestation with ACM type I and FXI deficiency who presented for induction of labor. Multidisciplinary planning involved hematology, neurology, neurosurgery, obstetrics, and anesthesiology. Given her bleeding history, hematology recommended prophylactic fresh frozen plasma (FFP) transfusion and tranexamic acid (TXA). Due to symptomatic ACM and risk of cerebrospinal fluid leak with neuraxial anesthesia, epidural placement was deferred. Analgesia was managed with remifentanil PCA. As labor progressed, the patient elected for cesarean delivery despite increased bleeding risk. General anesthesia was chosen, and the patient received perioperative FFP and TXA. Intraoperative blood loss was estimated at 2600 milliliters, requiring transfusion of 1 unit of packed red blood cells while maintaining stable hemodynamics. Postoperatively, the patient remained hemodynamically stable with no neurologic complications and was discharged home on postoperative day five. While neuraxial anesthesia can be considered in isolated ACM or FXI deficiency with appropriate precautions, the coexistence of both disorders amplifies the risks of neurologic deterioration and spinal hematoma. General anesthesia provided a controlled and safe alternative in this setting. This case underscores the importance of individualized anesthetic planning, multidisciplinary coordination, and careful hemostatic optimization. The simultaneous presence of ACM and FXI deficiency in an obstetric patient presents unique anesthetic and obstetric challenges. General anesthesia with proactive hemostatic management may be the safest approach when symptomatic ACM coexists with a significant bleeding risk. This case report describes the successful multidisciplinary peripartum management of a patient with both symptomatic ACM and FXI deficiency, highlighting the anesthetic dilemma and the rationale for ultimately selecting general anesthesia for cesarean delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.